Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 04, 2018 17:50 ET | Source: IMV Inc.

IMV Inc. Celebrates Grand Opening of New Facility in Dartmouth, Nova Scotia

DARTMOUTH, Nova Scotia, Sept. 04, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, celebrated its grand opening today of its new facilities in...
August 23, 2018 07:05 ET | Source: IMV Inc.

IMV Inc. to Present at the H.C. Wainwright 20th Annual Global Investment Conference

HALIFAX, Nova Scotia, Aug. 23, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that Chief Executive Officer Frederic Ors and...
August 09, 2018 07:05 ET | Source: IMV Inc.

IMV Inc. Reaches Multiple Milestones in Advanced Ovarian Cancer Clinical Trial

HALIFAX, Nova Scotia, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Enrollment Completed for Phase 1b CohortsFirst Dosing Occurred in Phase 2 Portion of the Program IMV Inc. (Nasdaq: IMV; TSX: IMV), a...
August 08, 2018 07:05 ET | Source: IMV Inc.

IMV Inc. Announces Q2 2018 Financial Results

Initiated Trading of Common Shares on Nasdaq; Finalized Corporate Name ChangePresented New Positive Data at ASCO on the DECIDE1 trial in Ovarian CancerAdvanced Ongoing Clinical Programs with Merck and...
July 31, 2018 07:05 ET | Source: IMV Inc.

IMV Inc. to Announce Second Quarter 2018 Financial Results and Host Earnings Call on August 8, 2018

HALIFAX, Nova Scotia, July 31, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (“IMV” or the “Corporation”) (Nasdaq:IMV) (TSX:IMV), a clinical stage immunotherapy company, announced today that it will hold a...
July 25, 2018 07:05 ET | Source: IMV Inc.

IMV Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference

HALIFAX, Nova Scotia, July 25, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq:IMV) (TSX:IMV), a clinical stage immuno-oncology corporation, today announced that IMV Chief Executive Officer Frederic Ors...
June 07, 2018 07:05 ET | Source: IMV Inc.

IMV Inc. Appoints Julia P. Gregory to Board of Directors

HALIFAX, Nova Scotia, June 07, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (“IMV” or the “Corporation”) (Nasdaq:IMV) (TSX:IMV), a clinical stage immunotherapy company, announced today the addition of Julia P....
June 03, 2018 10:57 ET | Source: IMV Inc.

IMV Inc. (Formerly Immunovaccine Inc.) Presents New Positive Data From Phase 1b/2 Combination Clinical Trial in Advanced Ovarian Cancer at 2018 ASCO Meeting

Combination Immunotherapy Continues to Show Tolerable Safety Profile and Promising Activity With Second Dosing Cohort Showing 6 of the First 8 Evaluable Participants Exhibiting Stable Disease at First...
May 31, 2018 07:05 ET | Source: IMV Inc.

Nasdaq Approves Listing of IMV Inc. Common Shares

HALIFAX, Nova Scotia, May 31, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (“IMV” or the “Corporation”) (TSX:IMV) (OTCQX:IMMVD), a clinical stage immunotherapy company, today announced that its common shares...
May 30, 2018 16:35 ET | Source: IMV Inc.

IMV Leadership to Participate in Upcoming Investor and Business Development Conferences

HALIFAX, Nova Scotia, May 30, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (TSX:IMV) (OTCQX:IMMVD), a clinical stage immuno-oncology company, today announced details on upcoming industry presentations that the...